Elicio Therapeutics, Inc. Shareholders' Equity
Elicio Therapeutics, Inc. (ELTX) had Shareholders' Equity of $7.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.94M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.44M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.64M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.82M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $7.94M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$1.44M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $1.64M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.82M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $8.90M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$11.31M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$18.99M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.65M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $4.87M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $11.37M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $13.29M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $23.56M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | -$109.88M 10-Q · filed 2024-11-13 | $39.67M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$102.14M 10-K · filed 2025-03-31 | $43.77M 10-K · filed 2023-03-17 |
| 2022-09-30 | -$95.70M 10-Q · filed 2023-11-13 | $50.21M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$88.62M 10-Q · filed 2023-11-13 | $59.76M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$81.44M 10-Q · filed 2023-11-13 | $67.20M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$74.54M 10-K · filed 2024-03-29 | $81.51M 10-K · filed 2022-03-30 |
| 2021-09-30 | $64.51M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $77.19M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $92.44M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$90.45M 10-K · filed 2023-03-17 | |
| 2020-09-30 | -$63.19M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$49.10M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | -$30.68M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | -$18.59M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |